Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1998
12/15/1998US5849769 N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
12/15/1998US5849765 Tetrahydropyridine derivatives as dopamine receptor subtype ligands
12/15/1998US5849763 Use of levobupivacaine as an anesthetic agent
12/15/1998US5849762 Peripherally acting anti-pruritic opiates
12/15/1998US5849761 Peripherally active anti-hyperalgesic opiates
12/15/1998US5849760 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors
12/15/1998US5849759 Naphthyl-substituted benzimidazole derivatives as anti-coagulants
12/15/1998US5849756 Pharmaceutical composition and method for modulating the immune reaction
12/15/1998US5849755 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
12/15/1998US5849753 Pyridyl imidazole derivatives and processes for the preparation thereof
12/15/1998US5849752 Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
12/15/1998US5849751 Amides and sulphonamides of benzylamines having heterocyclic substituents
12/15/1998US5849749 6-(hydroxymethyl-ethyl)pyridines
12/15/1998US5849748 Therapeutic quassinoid preparations with antineoplastic antiviral, and herbistatic activity
12/15/1998US5849747 N, n-disubstituted amic acid derivatives
12/15/1998US5849746 Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT1D receptor agonists
12/15/1998US5849745 N-benzylpiperazine compounds
12/15/1998US5849744 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonist
12/15/1998US5849743 Quinoxalines and drugs prepared therefrom
12/15/1998US5849742 Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis
12/15/1998US5849740 Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
12/15/1998US5849739 5-arylindole derivatives
12/15/1998US5849738 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
12/15/1998US5849737 Compositions and methods for treating pain
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849729 Use of hydrolyzed cocoa butter for percutaneous absorption
12/15/1998US5849728 Desquamation compositions
12/15/1998US5849726 Anhydrous alendronate monosodium salt formulations
12/15/1998US5849723 Fungicides for the control of take-all disease of plants
12/15/1998US5849721 Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof
12/15/1998US5849720 Enhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucans
12/15/1998US5849714 Treatment of bacterial dysentery
12/15/1998US5849711 Cathepsin and methods and compositions for inhibition thereof
12/15/1998US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
12/15/1998US5849709 Saccharopeptides and derivatives thereof
12/15/1998US5849706 Method of treating retained asthma pulmonary secretions
12/15/1998US5849691 Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
12/15/1998US5849689 Method of extending the plasma half-life of deletion variants of hepatocyte growth factor
12/15/1998US5849587 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
12/15/1998US5849578 Compositions and methods for the treatment and diagnosis of cardiovascular using RCHD528 as a target
12/15/1998US5849535 Human growth hormone variants
12/15/1998US5849509 Nuclear matrix proteins
12/15/1998US5849485 Liver enriched transcription factor
12/15/1998US5849482 Crosslinking oligonucleotides
12/15/1998US5849337 Method of enhancing magnesium absorption and prevention of atherosclerosis
12/15/1998US5849329 Process for preparing pharmaceutical composition having an increased active substance dissolution rate, and the compositions obtained
12/15/1998US5849326 Method for treating neuronal diseases via administration of 2-acylaminopropanol derivatives
12/15/1998US5849324 Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
12/15/1998US5849322 Compositions and methods for buccal delivery of pharmaceutical agents
12/15/1998US5849312 Therapeutic/cosmetic compositions comprising bradykinin antagonist for treating sensitive human skin
12/15/1998US5849290 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/15/1998US5849263 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/15/1998US5849240 Method of preparing sustained release pharmaceutical compositions
12/15/1998CA2163667C Imidazole lipoxygenase inhibitors
12/15/1998CA2163534C Inhibition of hair growth
12/15/1998CA2162186C Pradimicin derivatives
12/15/1998CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
12/15/1998CA2152541C Herpes ribonucleotide reductase inhibitors
12/15/1998CA2134677C Retinoic acid-containing compositions
12/15/1998CA2101274C Microbial oil mixtures and uses thereof
12/15/1998CA2092653C Substituted pyrrolidine derivatives as hiv protease inhibitors
12/15/1998CA1340276C Heterocyclic compounds
12/15/1998CA1340275C Heterocyclic compounds
12/15/1998CA1340274C (1r,5s,6s)-2-substituted thio-6-¬(r)-1-hydroxy-ethyl|-1-methyl-carbapenem-3-carboxylic acid derivatives
12/15/1998CA1340273C 6-substituted thia-aza compounds
12/15/1998CA1340254C Alkylthio-alkylsulphinyl and alkylsulphonyl substituted thiophene-2-carboxamides and their use as pharmaceuticals
12/15/1998CA1340253C B-lactam antibiotics
12/15/1998CA1340247C Choline salts of arylmethylenyl thiazolidinones and oxazolidinones
12/15/1998CA1340246C Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and athersclerosis
12/15/1998CA1340223C 3,3-diphenylpropyl amines and pharmaceutical compositions and cholinergic uses thereof
12/15/1998CA1340216C Heterocyclic compounds
12/15/1998CA1340215C Cc-1065 analogs having two cpi subunits
12/15/1998CA1340205C Alkylene diamines
12/15/1998CA1340192C Cyclic amine compound
12/15/1998CA1340187C Peptides that inhibit von willebrand factor binding
12/13/1998CA2240312A1 .beta.-adrenergic agonists to reduce a wasting condition
12/13/1998CA2240305A1 Process for the preparation of (1s,2r)-1-amino-2-indanol-(r,r)-tartrate methanol solvate
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055646A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
12/10/1998WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/10/1998WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity
12/10/1998WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998WO1998055598A1 A METHOD OF INHIBITING CANCER CELL GROWTH USING A VECTOR EXPRESSING pRb2/p130
12/10/1998WO1998055515A1 Modified low molecular weight heparin that inhibits clot associated coagulation factors
12/10/1998WO1998055514A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998WO1998055512A2 Smad-interacting polypeptides and their use
12/10/1998WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998WO1998055505A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/10/1998WO1998055499A1 11β-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
12/10/1998WO1998055498A1 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
12/10/1998WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998WO1998055493A1 Natural antitumor or antiviral substances and use of the same
12/10/1998WO1998055491A1 Process for preparing etoposide
12/10/1998WO1998055490A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998WO1998055488A1 Quadratically planar coordinated platinum(ii) complexes, the production and use thereof
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055481A1 Benzonaphthyridine
12/10/1998WO1998055480A1 Substituted 1h-pyridinyl-2-ones as gabaaalpha 2/3 ligands
12/10/1998WO1998055479A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055478A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
1 ... 6567 6568 6569 6570 6571 6572 6573 6574 6575 6576 6577 6578 6579 6580 6581 6582 6583 6584 6585 6586 6587 ... 7860